SurgiVance, a leading innovator in developing AI-driven, direct-to-digital confocal pathology, announced today that Michael Li, PhD has been appointed Chief Executive Officer.
Read More"Year-after-year of Medicare funding cuts to independent medical practices must be stopped, and we will continue our congressional advocacy efforts to implement long-term solutions, like inflationary adjustments for independent providers," said Bob Still, Executive Director of the Radiology Business Management Association (RBMA).
Read MoreThe Network Operations Center Module shows advanced digital signage views for clients deploying numerous devices, which improves efficiency through real-time display previews, health metrics, and network pathway troubleshooting.
Read MorePorter has been closing care and quality gaps in the home through their Care Guides, and this expansion allows it to go further addressing risk adjustment gaps extending the platform in a first of its kind comprehensive quality stars and care coordination model.
Read MoreP23 Labs, a leading molecular laboratory, is kicking off its 23 Days of Giving series of charitable events running from Dec. 1 to Dec. 23, 2022. Three of these days will be dedicated to gifts to the company's team members and 20 days are for charitable donations to causes from P23 and its partner, Laddia Whittier, who made a generous contribution to make this initiative possible.
Read More"Congress must stop these double-digit, devastating cuts to independent Medicare doctors and their patients to ensure all Americans receive affordable, quality healthcare," said Bob Still, Executive Director of the RBMA.
Read MoreP23 Health provides consumers with flexibility and control over their health journey: at-home molecular testing kits, skincare products, dietary supplements, and healthcare guidance.
Read MoreBioDerm, Inc., a leading provider of disposable medical devices and wound care supplies, announced a new distribution deal with TillaCare Ltd, an Israeli designer and manufacturer of external urine collection devices.
Read MoreSenzo, a global life sciences company developing high-accuracy, low-cost, point-of-care diagnostic technologies, today announced a partnership with BARDA, part of the Administration for Strategic Preparedness and Response (ASPR), in the US Department of Health and Human Services (HHS) to assist in bringing Senzo's Amplified Lateral Flow (ALF) COVID-19 test in achieving U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) to market.
Read MoreClinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators
Read More